The infectious etiology of vasculitis

Autoimmunity

Volumn 42, Issue 5, 2009, Pages 432-438

  Lidar, Merav ^a   Lipschitz, Noga ^b   Langevitz, Pnina ^a   Shoenfeld, Yehuda ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b SMC   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Infection; Pathogenesis; Vasculitis

Indexed keywords

BORRELIA BURGDORFERI; CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; NONHUMAN; PARVOVIRUS; PATHOGENESIS; POLYARTERITIS NODOSA; REVIEW; RICKETTSIACEAE; SMALL VESSEL VASCULITIS; STAPHYLOCOCCUS AUREUS; TREPONEMA PALLIDUM; VARICELLA ZOSTER VIRUS; VASCULITIS;

BACTERIA; BACTERIAL INFECTIONS; HUMANS; VASCULITIS; VIRUS DISEASES; VIRUSES;

EID: 70749150628     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802613210     Document Type: Review

References (91)

1. Jennette JC, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
2. Rodriguez-Pla A, Stone JH. Vasculitis and systemic infections. Curr Opin Rheumatol 2006;18:39-47.
3. Cohen-Teravet JW, Stegeman CA. Infections and vaculitis. In: ShoenfeldY,RoseNY, editors. Infections and autoimmunity. Amsterdam/San Diego: Elsevier; 2004. p 549-557.
4. Misiani R. Virus-associated vasculitides: Pathogenesis. In: Hoffman GS,Weyand CM, editors. Inflammatory diseases of blood vessels. New York: Marcel Dekker; 2002. p 553-564.
5. Bechah Y, et al. Infection of endothelial cells with virulent Rickettsia prowazekii increases the transmigration of leukocytes. J Infect Dis 2008;197:142-147.
6. Matussek A, et al. Infection of human endothelial cells with Staphylococcus aureus induces transcription of genes encoding an innate immunity response. Scand J Immunol 2005;61: 536-544.
7. Beekhuizen H, et al. Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes. J Immunol 1997;158: 774-782.
8. Ferri C, Zignego A. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 2000;12:53-60.
9. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl JMed 1992;327: 1490-1495.
10. Strassburg CP, Vogel A, Manns MP. Autoimmunity and hepatitis C. Autoimmun Rev 2003;2:322-331.
11. Theofilopoulos AN, Dixon FJ. Immune complexes in human diseases: A review. Am J Pathol 1980;100:529-594.
12. Stokol T, et al. C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment. J Exp Med 2004;200: 835-846.
13. Feng X, et al. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol 2002;168:2441-2448.
14. Racanelli V, et al. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 2001;167:21-29.
15. Cheema GS, et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 2001;44:1313-1319.
16. Sene D, et al. Hepatitis C virus-associated B-cell proliferation- the role of serum B lymphocyte stimulator (BLyS/ BAFF). Rheumatology (Oxford) 2007;46:65-69.
17. De Vita S, Quartuccio L, Fabris M. Hepatitis C virus infection, mixed crioglobulinemia cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both Autoimmun Rev, in press.
18. Baker KP. BLyS-an essential survival factor for B cells: Basic biology, links to pathology and therapeutic target. Autoimmun Rev 2004;3:368-375.
19. Ram M, Gershwin ME, Shoenfeld Y. Hepatitis B Virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 2008;34: 85-102.
20. Duffy J, et al. Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore) 1976;55:19-37.
21. Gower RG, et al. Small vessel vasculitis caused by hepatitis B virus immune complexes. Small vessel vasculitis and HBsAG. J Allergy Clin Immunol 1978;62:222-228.
22. Naides SJ. Known causes of vasculitis in man. Cleve Clin J Med 2002;2(69 Suppl):SII15-SII19.
23. Guillevin L, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995;74:238-253.
24. Guillevin L, et al. Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 2005;84: 313-322.
25. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: The case against autoimmune intervention in pathogenesis. J Autoimmun 2001;16: 269-274.
26. Guillevin L, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994;53:334-337. (Pubitemid 24164979)
27. Ferri C, et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev 2007;7:114-120.
28. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997;19:111-129. (Pubitemid 27417532)
29. Ferri C, Bombardieri S. HCV and cryoglobulinemia. In: Shoenfeld Y, RoseNR, editors. Infection and autoimmunity. Amsterdam/San Diego: Elsevier; 2004. p 201-212.
30. Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006;18:54-63.
31. Saadoun D, et al. Rituximab combined with Peg-Interferon- Ribavirin in refractory HCV-associated cryoglobulinemia vasculitis. Ann Rheum Dis, in press.
32. Genereau T, et al. Temporal arteritis symptoms in a patient with hepatitis C virus associated type II cryoglobulinemia and small vessel vasculitis. J Rheumatol 1998;25:183-185.
33. Ferraccioli GF, et al. Jaw and leg claudication in a patient with temporal arteritis, chronic sialoadenitis and previous hepatitis C virus infection. Clin Exp Rheumatol 1998;16:463-468.
34. Vassilopoulos D. Hepatitis C infection and vasculitis. In: Shoenfeld Y, RoseNR, editors. Infection and autoimmunity. Amsterdam/San Diego: Elsevier; 2004. p 189-200.
35. Font C, et al. Polyarteritis nodosa in human immunodeficiency virus infection: Report of four cases and review of the literature. Br J Rheumatol 1996;35:796-799.
36. Pagnoux C, Cohen P, Guillevin L. Vasculitides secondary to infections. Clin Exp Rheumatol 2006;24:S71-S81.
37. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002;1:329-337.
38. Gherardi R, et al. Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 1989;321:685-686.
39. Calabrese LH. The rheumatic manifestations of infection with the human immunodeficiency virus. Semin Arthritis Rheum 1989;18:225-239.
40. Nieuwhof CM, Damoiseaux J, Cohen Tervaert JW. Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment. Ann Rheum Dis 2006;65:1677-1678.
41. Cioc AM, et al. Parvovirus B19 associated adult Henoch Schonlein purpura. J Cutan Pathol 2002;29:602-607.
42. Corman LC, Dolson DJ. Polyarteritis nodosa and parvovirus B19 infection. Lancet 1992;339:491.
43. Baskan EB, et al. Detection of parvovirus B19 DNA in the lesional skin of patients with Behcet's disease. Clin Exp Dermatol 2007;32:186-190.
44. LehmannHW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2003;2: 218-223.
45. Helweg-Larsen J, et al. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 2002;41:445-449.
46. Eden A, et al. Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: A casecontrol study. Rheumatology (Oxford) 2003;42:660-664.
47. Finkel TH, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent Lancet 1994;343:1255-1258.
48. Severin MC, Shoenfeld Y. Parvovirus B19 infection and its association to autoimmune disease. In: Shoenfeld Y, Rose NR, editors. Infection and autoimmunity. Amsterdam/San Diego: Elsevier; 2000. p 181-188.
49. Martinelli C, et al. Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: Report of a case. Aids 1997;11:1891-1893.
50. Crowson AN, Magro CM, Dawood MR. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 2000;27:505-515.
51. Golden MP, et al. Cytomegalovirus vasculitis. Case reports and review of the literature. Medicine (Baltimore) 1994;73: 246-255.
52. Meyer MF, et al. Cytomegalovirus infection in systemic necrotizing vasculitis: Causative agent or opportunistic infectioň Rheumatol Int 2000;20:35-38.
53. Taniwaki S, et al. Multiple ulcers of the ileum due to Cytomegalovirus infection in a patient who showed no evidence of an immunocompromised state. J Gastroenterol 1997;32:548-552.
54. Orloff JJ, et al. Toxic megacolon in cytomegalovirus colitis. Am J Gastroenterol 1989;84:794-797.
55. Koeppen AH, et al. Central nervous system vasculitis in cytomegalovirus infection. J Neurol Sci 1981;51:395-410.
56. Morgello S, et al. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: An autopsy study of 30 cases and a review of the literature. Hum Pathol 1987;18: 289-297.
57. Magro CM, Crowson AN, Ferri C. Cytomegalovirusassociated cutaneous vasculopathy and scleroderma sans inclusion body change. Hum Pathol 2007;38:42-49.
58. Swanson S, Feldman PS. Cytomegalovirus infection initially diagnosed by skin biopsy. Am J Clin Pathol 1987;87:113-116.
59. Caruso JM, Tung GA, Brown WD. Central nervous system and renal vasculitis associated with primary varicella infection in a child. Pediatrics 2001;107:E9.
60. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections of the nervous system: Clinical and pathologic correlates. Arch Pathol Lab Med 2001;125:770-780.
61. Jain R, et al. Varicella-zoster vasculitis presenting with intracranial hemorrhages. AJNR Am J Neuroradiol 2003;24: 971-974.
62. Gilden DH, et al. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000;342:635-645.
63. Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH. The patterns of varicella zoster virus encephalitis. Hum Pathol 1996;27:927-938.
64. Feigl D, Feigl A, Edwards JE. Mycotic aneurysms of the aortic root. A pathologic study of 20 cases. Chest 1986;90:553-557.
65. Miranda-Filloy JA, et al. Microscopic polyangiitis following recurrent Staphylococcus aureus bacteremia and infectious endocarditis. Clin Exp Rheumatol 2006;24:705-706.
66. Fleischer B, Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med 1988;167: 1697-1707.
67. Stegeman CA, et al. Trimethoprim-sulfamethoxazole (cotrimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996;335:16-20.
68. Yagi JJ, Rath S, Janeway Jr CA. Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism. J Immunol 1991;147:1398-1405.
69. Popa ER, Tervaert JW. The relation between Staphylococcus aureus and Wegener's granulomatosis: Current knowledge and future directions. Intern Med 2003;42:771-780.
70. George J, et al. Infections and Wegener's granulomatosis-a cause and effect relationship QJM 1997;90:367-373.
71. Voswinkel J, et al. B lymphocyte maturation in Wegener's granulomatosis: A comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006;65:859-864.
72. Brons RH, et al. Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis Clin Exp Immunol 2000;119: 566-573.
73. Matsubara K, Fukaya T. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis 2007;20:298-303.
74. Tervaert JW, Popa ER, Bos NA. The role of superantigens in vasculitis. Curr Opin Rheumatol 1999;11:24-33.
75. Cimaz R, Falcini F. An update on Kawasaki disease. Autoimmun Rev 2003;2:258-263.
76. Kao GF, et al. Cutaneous histopathology of Rocky Mountain spotted fever. J Cutan Pathol 1997;24:604-610.
77. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: Emerging diseases challenging old concepts. Clin Microbiol Rev 2005;18:719-756.
78. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998; 352:557-565.
79. Mikkila HO, et al. The expanding clinical spectrum of ocular lyme borreliosis. Ophthalmology 2000;107:581-587.
80. Halperin JJ, et al. Lyme neuroborreliosis: Central nervous system manifestations. Neurology 1989;39:753-759.
81. Oksi J, et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996; 119(Pt 6):2143-2154.
82. Komdeur R, et al. Immunosuppressive treatment for vasculitis associated with Lyme borreliosis. Ann Rheum Dis 2001;60: 721.
83. Pizzarello LD, et al. Temporal arteritis associated with Borrelia infection. A case report. J Clin Neuroophthalmol 1989;9:3-6.
84. Dourmishev LA, Dourmishev AL. Syphilis: Uncommon presentations in adults. Clin Dermatol 2005;23:555-564.
85. Kennedy JL, Barnard JJ, Prahlow JA. Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction and death. Cardiology 2006;105:25-29.
86. Tavora F, Burke A. Review of isolated ascending aortitis: Differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis. Pathology 2006;38:302-308.
87. MacLeod CB, Johnson D, Frable WJ. "Tree-barking" of the ascending aorta. Syphilis or systemic lupus erythematosusl Am J Clin Pathol 1992;97:58-62.
88. O'Regan AW, et al. Barking up the wrong tree Use of polymerase chain reaction to diagnose syphilitic aortitis. Thorax 2002;57:917-918.
89. Aldave AJ, King JA, Cunningham Jr ET. Ocular syphilis. Curr Opin Ophthalmol 2001;12:433-441.
90. Yokoi M, Kase M. Retinal vasculitis due to secondary syphilis. Jpn J Ophthalmol 2004;48:65-67.
91. Chao YC, et al. A large ulcer and cutaneous small-vessel vasculitis associated with syphilis infection. Scand J Rheumatol 2006;35:147-151.